{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.582","meta":{"versionId":"7","lastUpdated":"2019-03-19T01:00:22.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.582","version":"20190319","name":"Reason for not administering Trastuzumab documented","status":"active","date":"2019-03-19T01:00:22-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","concept":[{"code":"G9836","display":"Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)"}]}]}}